Current Report Filing (8-k)
April 21 2014 - 9:07AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 OR 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported):
April 16, 2014
POSITIVEID CORPORATION
(Exact name of registrant as specified in
its charter)
|
|
|
|
|
DELAWARE |
|
001-33297 |
|
06-1637809 |
(State or other jurisdiction of incorporation) |
|
(Commission File Number) |
|
(IRS Employer Identification No.) |
|
|
|
1690 SOUTH CONGRESS AVENUE, SUITE 201
DELRAY BEACH, FLORIDA |
|
33445 |
(Address of principal executive offices) |
|
(Zip Code) |
Registrant’s telephone number, including
area code: 561-805-8008
N/A
(Former name or former address if changed
since last report.)
Check the appropriate box below if the Form 8-K filing is intended
to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the
Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the
Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b)
under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c)
under the Exchange Act (17 CFR 240.13e-4(c)) |
| Item
5.02. | Departure
of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain
Officers. |
Effective April
16, 2014, Lyle L. Probst, was appointed President of PositiveID Corporation (the “Company”). Mr. Probst, age 43,
who has 15 years of management experience with large bio-detection programs and products, joined PositiveID in 2011 at the
time that PositiveID acquired Microfluidic Systems, based in Pleasanton, CA.
Before joining
Microfluidic Systems, Mr. Probst directed bio-detection programs at Lawrence Livermore National Laboratory
(“LLNL”). While he was at LLNL, he managed a series of programs such as the Department of Homeland
Security Science & Technology BAND (Bioagent Autonomous Networked Detector) program, and the development and deployment
of BioWatch Generation 1 at LLNL, and was principal investigator/developer of the high-throughput BioWatch mobile laboratory
at SAIC. Mr. Probst was previously the Director of Capillary Electrophoresis and Director of Chemistries at the Joint Genome
Institute. He holds a B.S. in Biology and an M.B.A in Executive Management.
Family Relationships
No
family relationship has ever existed between Mr. Probst and the Company.
Related Party
Transactions
There
are no related party transactions reportable under Item 5.02 of Form 8-K and Item 404(a) of Regulation S-K.
Compensation
Mr.
Probst and the Company have not entered into an employment agreement as a result of Mr. Probsts’s appointment
as the President of the Company. Mr. Probst’s base salary is $200,000 per year.
On
April 21, 2014, the Company issued a press release announcing the appointment of Mr. Probst, a copy of which is attached to this
Report as Exhibit 99.1.
| Item 9.01. | Financial Statements and Exhibits. |
(d) Exhibits
Exhibit
Number |
|
|
Description |
|
|
|
|
99.1 |
|
|
Press Release dated April 21, 2014 announcing Mr. Probst’s appointment as PositiveID Corporation’s President |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
PositiveID Corporation |
|
|
Date: April 21, 2014 |
|
|
|
|
By: |
/s/ William J. Caragol |
|
|
William J. Caragol Chief Executive Officer |